Coby Meijer
Impact in
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
- Inflammatory Biomarkers in Disease Prognosis
- Cancer-related Molecular Pathways
- Cancer Research top 5%
Papers in
-
- Cancer therapeutics and mechanisms 12
- RNA Interference and Gene Delivery 7
- Angiogenesis and VEGF in Cancer 5
- Oncology 37
- Drug Transport and Resistance Mechanisms 20
- Lung Cancer Research Studies 8
- Co-authors
- Nanno H. Mulder (30 shared papers)Elisabeth G.E. de Vries (40 shared papers)Geke A.P. Hospers (15 shared papers)Rik J. Scheper (3 shared papers)Paul van der Valk (5 shared papers)G J Zaman (2 shared papers)Wendy Dam (12 shared papers)Yoka H. Kusumanto (5 shared papers)
- Journals
- International Journal of Cancer (10 papers)British Journal of Cancer (9 papers)Journal of Clinical Oncology (6 papers)Cancer Chemotherapy and Pharmacology (4 papers)European Journal of Cancer (4 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Coby Meijer
110 papers receiving 5.0k citations
Coby Meijer's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 2.5k
- Cancer Research 479
- Pediatrics, Perinatology and Child Health 567
- Biochemistry 236
- Molecular Biology 1.8k
Countries citing papers authored by Coby Meijer
This map shows the geographic impact of Coby Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coby Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coby Meijer more than expected).
Fields of papers citing papers by Coby Meijer
This network shows the impact of papers produced by Coby Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coby Meijer. The network helps show where Coby Meijer may publish in the future.
Co-authors
The 25 scholars most cited alongside Coby Meijer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Hit paper breakdown → | 1994 | 551 |
| 2 | 2003 | 458 | |
| 3 | Tissue distribution of the multidrug resistance protein. | 1996 | 406 |
| 4 | 2001 | 311 | |
| 5 | 1990 | 212 | |
| 6 | Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. | 1992 | 185 |
| 7 | Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. | 1997 | 174 |
| 8 | Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. | 1996 | 151 |
| 9 | 1998 | 117 | |
| 10 | 2008 | 114 | |
| 11 | 1990 | 108 | |
| 12 | 2016 | 107 | |
| 13 | Multidrug resistance gene (P-glycoprotein) expression in the human fetus. | 1992 | 107 |
| 14 | Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. | 1999 | 87 |
| 15 | 2008 | 76 | |
| 16 | 2019 | 68 | |
| 17 | 1989 | 67 | |
| 18 | Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro. | 2010 | 67 |
| 19 | 2014 | 64 | |
| 20 | Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. | 1987 | 61 |
About Coby Meijer
Coby Meijer is a scholar working on Molecular Biology, Oncology, Surgery, Cancer Research and Epidemiology, having authored 114 papers that have together received 5.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (20 papers), Testicular diseases and treatments (12 papers), Cancer therapeutics and mechanisms (12 papers), Lung Cancer Research Studies (8 papers), RNA Interference and Gene Delivery (7 papers), Angiogenesis and VEGF in Cancer (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (479 citations), Pediatrics, Perinatology and Child Health (567 citations), Biochemistry (236 citations) and Molecular Biology (1.8k citations). Coby Meijer has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Nanno H. Mulder, Elisabeth G.E. de Vries, Geke A.P. Hospers, Rik J. Scheper, Paul van der Valk, G J Zaman, Wendy Dam, Yoka H. Kusumanto, George L. Scheffer and Michael Müller. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.